BioPharma Credit (BOPCF) Stock Price, News & Analysis

Company Overview

BioPharma Credit PLC (OTCMKTS: BOPCF) is a closed-ended investment company focused on providing financing solutions to the global biopharmaceutical sector. Registered in Guernsey and listed on the London Stock Exchange, the company offers debt and royalty-based capital to companies developing therapeutics and medical technologies. Its mandate centers on delivering non-dilutive funding at various stages of clinical and commercial development, helping bridge the financing gap common in biotech innovation.

The firm’s product suite includes senior secured loans, revenue-based financing agreements and royalty monetization structures tailored to the unique cash-flow profiles of biotech and life sciences companies. By advancing capital against future sales or milestone payments, BioPharma Credit enables small and mid-cap drug developers to pursue research, clinical trials and regulatory approvals without issuing common equity or diluting existing shareholder stakes.

BioPharma Credit serves a diversified portfolio of clients across North America and Europe, spanning therapeutic areas such as oncology, rare diseases, immunology and neurology. The company typically targets projects with established proof-of-concept data or strong late-stage pipelines, combining rigorous scientific due diligence with financial underwriting to manage risk and optimize returns for shareholders.

The company’s investment activities are overseen by BioPharma Credit Management Limited, its dedicated UK-based adviser. Governance is provided by a board of directors with extensive experience in biopharma research, healthcare investment and fund management. Through disciplined deal sourcing and active portfolio monitoring, BioPharma Credit seeks to deliver attractive risk-adjusted yield while supporting innovation across the life sciences industry.

Key Stats

• Today's Range: $0.90 to $0.90
• 50-Day Range: $0.84 to $0.94
• 52-Week Range: $0.78 to $0.94
• Volume: N/A
• Average Volume: 358,165 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BOPCF Stock Analysis - Frequently Asked Questions

How have BOPCF shares performed this year?

BioPharma Credit's stock was trading at $0.8130 on January 1st, 2025. Since then, BOPCF stock has increased by 10.9% and is now trading at $0.9013.

How do I buy shares of BioPharma Credit?

Shares of BOPCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:BOPCF
• CIK: N/A
• Web: www.bpcruk.com
• Phone: 011 44 1392 477 503
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A